18F-OP-801

N/A

Report date: 2025/11/26 17:11:24

Base Information

Drug Name18F-OP-801
Drug Alias Name18F Hydroxyl Dendrimer18F-OP-80118-F-OP-801OP-80118F-HD
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAshvattha Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAshvattha Therapeutics
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A